
|Videos|August 18, 2022
Historic and Current Treatment Options for mUM
Author(s)Sunandana Chandra, MD, MS
An expert provides an overview of the historical and currently available treatment options in metastatic uveal melanoma (mUM), including the bispecific T-cell receptor immunotherapy tebentafusp (“teh-BEN-tah-fuhsp”).
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
A Gift from the Sea
2
Top 3 Takeaways From WCLC 2026 That Patients Should Know
3
New Myeloma Combo Cuts Risk of Relapse by Up to 72% — Here's What It Could Mean for You
4
After His Daughter’s Cancer Treatment, AJ Wyman Realized He Needed Help, Too
5

